Screener
Biohaven BHVN Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Biohaven’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001935979-26-000045
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 336,906 | 399,375 |
| Commitments and contingencies (Note 12) | ||
| Shareholders' (Deficit) Equity: | ||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common shares, no par value; 200,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 150,506,490 and 132,775,113 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2,132,908 | 1,934,276 |
| Additional paid-in capital | 203,358 | 193,984 |
| Accumulated deficit | (2,215,068) | (2,084,536) |
| Accumulated other comprehensive income | 8,302 | 8,348 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Biohaven's preferred stock, shares authorized?
- Biohaven (BHVN) reported preferred stock, shares authorized of $10M in Q1 2026.
- How has Biohaven's preferred stock, shares authorized changed year-over-year?
- Biohaven's preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Biohaven's preferred stock, shares authorized?
- Over 3 years (2022 to 2025), Biohaven's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.
Ask your AI about Biohaven's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude